Industry

Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including Sickle Cell Disease

– Precision to Receive $75 Million Upfront for a Single Target; Precision Eligible to Receive up to an Additional $1.4 Billion in Milestones and Tiered Royalties on Sales of Licensed Products – Precision to Develop a Single ARCUS® Nuclease Designed for Safe and Efficient In Vivo Gene Insertion – Collaboration Combines Precision’s Proprietary ARCUS Genome … [Read more…]

Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer

WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and liver diseases, announced today that it has filed suit in United States District Court for the District of Massachusetts against Pfizer, Inc. seeking damages for infringement of U.S. Patent No. 11,358,953 (the ’953 … [Read more…]

YesCare Announces New Partnership with Manatee County Sheriff to Provide Correctional Healthcare Services

Leading Correctional Healthcare Provider Will Bring Enhanced Reentry Services, Increased Behavioral Health Programming & Expanded Telehealth and Technology Capabilities to MSO BRADENTON, Fla.–(BUSINESS WIRE)–YesCare, the preeminent leader in correctional healthcare services, announced today a new partnership with the Manatee County Sheriff’s Office (MSO). Formerly known as Corizon Health, YesCare officially launched last month with a … [Read more…]

Results From Phase 3 PROpel Trial of LYNPARZA® (olaparib) Plus Abiraterone in First-Line Metastatic Castration-Resistant Prostate Cancer Published in NEJM Evidence

RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the results from the Phase 3 PROpel trial have been published in NEJM Evidence. Results from the trial showed that LYNPARZA in combination with abiraterone plus prednisone significantly improved radiographic progression-free survival (rPFS) versus abiraterone … [Read more…]

Purdue Pharma Introduces Nalmefene HCl Injection, 2mg/2mL (1mg/1mL) in the U.S. for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids

Company will distribute injectable nalmefene for no profit as part of its commitment to help abate the opioid crisis STAMFORD, Conn.–(BUSINESS WIRE)–Purdue Pharma L.P. announced today that Nalmefene Hydrochloride injection, 2mg/2mL (1mg/1mL) is now available in the U.S. for use by healthcare professionals. Nalmefene is an opioid antagonist indicated for the complete or partial reversal … [Read more…]

Eurofins Successfully Prices New €600m 7-Year 4%-Coupon Senior Unsecured Bonds

LUXEMBOURG–(BUSINESS WIRE)–Regulatory News: Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3/positive by Moody’s and BBB/stable- by Fitch, “Eurofins”), a global leader in bioanalytical testing, announces that it has successfully raised €600m in its latest senior unsecured Euro-denominated public bond issuance (the “Bonds”). The Bonds have a 7-year maturity (due on 6 July 2029) and will bear an … [Read more…]

AIT Worldwide Logistics Announces Sixth Annual Campaign to Support St. Jude Children’s Research Hospital®

Multiple AIT Cares fundraising events plus company match aim to raise more than $60,000 for pediatric treatment, research facility ITASCA, Ill.–(BUSINESS WIRE)–#ChildhoodCancer–AIT Worldwide Logistics is proud to announce its sixth year as a multi-market St. Jude Children’s Research Hospital® sponsor, supporting their mission to end childhood cancer. “Giving back to the communities where we live … [Read more…]

National Nonprofit, All Clear Foundation Pioneers Emergency Responder Mental Health Training Curriculum with Support from FirstNet, Built with AT&T in Five States

DENVER–(BUSINESS WIRE)–All Clear Foundation is a national nonprofit dedicated to supporting the wellbeing of the Emergency Responder community. The cumulative stress and trauma of Response work, whether in the field or medical setting, can erode a Responder’s health, wellbeing, and relationships. Many, unfortunately, experience a decreased personal quality of life as a consequence of the … [Read more…]

 CORRECTING and REPLACING Croma Aesthetics Canada Launches saypha® VOLUME PLUS

 Company will focus on untapped demographic groups that value aesthetics and a new definition of luxury TORONTO–(BUSINESS WIRE)–First paragraph, first sentence of release should read: Croma Aesthetics Canada Ltd., doing business as Hugel Aesthetics is pleased to announce the launch of saypha® VOLUME PLUS, a hyaluronic acid dermal filler product specifically designed to restore facial … [Read more…]

LifePoint Health Appoints Two Leaders to Top Executive Positions

Jason Zachariah named EVP, Chief Operating Officer and Aaron Lewis named EVP, Growth and Integrated Solutions BRENTWOOD, Tenn.–(BUSINESS WIRE)–LifePoint Health®, a diversified healthcare delivery network dedicated to its mission of Making Communities Healthier®, today announced that two of the organization’s current leaders have been promoted to new executive leadership roles within the company. Jason Zachariah … [Read more…]